{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:58:00Z","timestamp":1788541080472,"version":"build-2803163510"},"reference-count":115,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004257","name":"Helse Vest","doi-asserted-by":"publisher","award":["-12625"],"award-info":[{"award-number":["-12625"]}],"id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010738","name":"Stavanger Universitetssjukehus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.beem.2023.101786","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T12:06:03Z","timestamp":1686139563000},"page":"101786","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Optimal surgical approach for digestive neuroendocrine neoplasia primaries: Oncological benefits versus short and long-term complications"],"prefix":"10.1016","volume":"37","author":[{"given":"Kjetil","family":"S\u00f8reide","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Hallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel B.","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"St\u00e4ttner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2023.101786_bib1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncr.29099","article-title":"Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes","volume":"121","author":"Hallet","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.beem.2023.101786_bib2","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1186\/s12885-020-07581-y","article-title":"Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study","volume":"20","author":"Masui","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.beem.2023.101786_bib3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/bjs.10034","article-title":"Epidemiology and classification of gastroenteropancreatic neuroendocrine neoplasms using current coding criteria","volume":"103","author":"Sandvik","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/j.beem.2023.101786_bib4","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.beem.2023.101786_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000442207","article-title":"Trends in incidence of neuroendocrine neoplasms in Norway: a report of 16,075 cases from 1993 through 2010","volume":"104","author":"Boyar Cetinkaya","year":"2017","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2023.101786_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40618-022-01905-4","article-title":"Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies","volume":"46","author":"Ruggeri","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.beem.2023.101786_bib7","first-page":"471","article-title":"Gastroenteropancreatic neuroendocrine tumors","volume":"68","author":"Cives","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.beem.2023.101786_bib8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.gtc.2022.06.002","article-title":"Gastroenteropancreatic neuroendocrine tumors","volume":"51","author":"Fernandes","year":"2022","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.beem.2023.101786_bib9","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.annonc.2020.03.304","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Pavel","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.beem.2023.101786_bib10","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00261-020-02773-3","article-title":"Radiology of the neuroendocrine neoplasms of the gastrointestinal tract: a comprehensive review","volume":"46","author":"Malla","year":"2021","journal-title":"Abdom Radio (NY)"},{"key":"10.1016\/j.beem.2023.101786_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.654975","article-title":"The impact of (68)Gallium DOTA PET\/CT in managing patients with sporadic and familial pancreatic neuroendocrine tumours","volume":"12","author":"Cuthbertson","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2023.101786_bib12","article-title":"Gastroenteropancreatic neuroendocrine tumor diagnosis: DOTATATE PET\/CT","author":"Kandathil","year":"2022","journal-title":"PET Clin"},{"key":"10.1016\/j.beem.2023.101786_bib13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/SLA.0000000000005026","article-title":"Molecular genomic assessment using a blood-based mRNA signature (NETest) is cost-effective and predicts neuroendocrine tumor recurrence With 94% accuracy","volume":"274","author":"Modlin","year":"2021","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2023.101786_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12020-021-02754-6","article-title":"Insulinoma-associated protein 1(INSM1) is a superior marker for the diagnosis of gastroenteropancreatic neuroendoerine neoplasms: a meta-analysis","volume":"74","author":"Zhang","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2023.101786_bib15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000493318","article-title":"Unmet needs in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3)","volume":"108","author":"Sorbye","year":"2019","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2023.101786_bib16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.ecl.2018.05.001","article-title":"The problem of high-grade gastroenteropancreatic neuroendocrine neoplasms: well-differentiated neuroendocrine tumors, neuroendocrine carcinomas, and beyond","volume":"47","author":"Sorbye","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.beem.2023.101786_bib17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1159\/000511905","article-title":"A consensus-developed morphological Re-evaluation of 196 high-grade gastroenteropancreatic neuroendocrine neoplasms and its clinical correlations","volume":"111","author":"Elvebakken","year":"2021","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2023.101786_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000443168","article-title":"ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms","volume":"103","author":"Delle Fave","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2023.101786_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2023.101786_bib20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000443172","article-title":"ENETS consensus guidelines for high-grade gastroenteropancreatic neuroendocrine tumors and neuroendocrine carcinomas","volume":"103","author":"Garcia-Carbonero","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2023.101786_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000443170","article-title":"ENETS consensus guidelines update for neuroendocrine neoplasms of the Jejunum and Ileum","volume":"103","author":"Niederle","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2023.101786_bib22","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/MPA.0b013e3181ec1261","article-title":"The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum","volume":"39","author":"Anthony","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.beem.2023.101786_bib23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/MPA.0b013e3181ebb2a5","article-title":"The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum","volume":"39","author":"Boudreaux","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.beem.2023.101786_bib24","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/MPA.0b013e3181ebb168","article-title":"NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas","volume":"39","author":"Kulke","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.beem.2023.101786_bib25","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1080\/0284186X.2021.1921262","article-title":"Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms","volume":"60","author":"Janson","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.beem.2023.101786_bib26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ctrv.2016.05.003","article-title":"Diagnosis and management of gastrointestinal neuroendocrine tumors: an evidence-based Canadian consensus","volume":"47","author":"Singh","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.beem.2023.101786_bib27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.6004\/jnccn.2018.0056","article-title":"NCCN guidelines insights: neuroendocrine and adrenal tumors, version 2.2018","volume":"16","author":"Shah","year":"2018","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.beem.2023.101786_bib28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MPA.0000000000000850","article-title":"The North American Neuroendocrine Tumor Society Consensus guidelines for surveillance and medical management of midgut neuroendocrine tumors","volume":"46","author":"Strosberg","year":"2017","journal-title":"Pancreas"},{"key":"10.1016\/j.beem.2023.101786_bib29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/MPA.0000000000000846","article-title":"The surgical management of small bowel neuroendocrine tumors: consensus guidelines of the North American Neuroendocrine Tumor Society","volume":"46","author":"Howe","year":"2017","journal-title":"Pancreas"},{"key":"10.1016\/j.beem.2023.101786_bib30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11912-022-01200-8","article-title":"How to select patients affected by neuroendocrine neoplasms for surgery","volume":"24","author":"Fermi","year":"2022","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.beem.2023.101786_bib31","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1007\/s10620-021-07143-7","article-title":"Metastasis prevalence and survival of patients with T1-2 gastric neuroendocrine tumor treated with endoscopic therapy and surgery","volume":"67","author":"Wang","year":"2022","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.beem.2023.101786_bib32","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejca.2022.03.007","article-title":"The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms","volume":"168","author":"Borbath","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.beem.2023.101786_bib33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00423-020-01869-0","article-title":"Complications of surgery for gastro-entero-pancreatic neuroendocrine neoplasias","volume":"405","author":"Albers","year":"2020","journal-title":"Lange Arch Surg"},{"key":"10.1016\/j.beem.2023.101786_bib34","first-page":"80","article-title":"Early esophageal neuroendocrine tumor","volume":"35","author":"Branstetter","year":"2022","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.beem.2023.101786_bib35","article-title":"Large-cell esophageal neuroendocrine carcinoma: report of a rare case","volume":"14","author":"Galanis","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.beem.2023.101786_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12902-022-01016-4","article-title":"Epidemiology of neuroendocrine neoplasmas in Japan: based on analysis of hospital-based cancer registry data, 2009\u2005-\u20052015","volume":"22","author":"Koizumi","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.beem.2023.101786_bib37","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.1002\/cam4.4829","article-title":"Clinical characteristics, prognostic factors, and survival trends in esophageal neuroendocrine carcinomas: a population-based study","volume":"11","author":"Chen","year":"2022","journal-title":"Cancer Med"},{"key":"10.1016\/j.beem.2023.101786_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doad001","article-title":"Contemporary outcomes of esophageal and gastroesophageal junction neuroendocrine tumors","author":"Poston","year":"2023","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.beem.2023.101786_bib39","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1245\/s10434-018-6389-6","article-title":"Predicting survival and response to treatment in gastroesophageal neuroendocrine tumors: an analysis of the national cancer database","volume":"25","author":"Gray","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.beem.2023.101786_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2023.01.037","article-title":"Epidemiology of gastric malignancies 2000-2018 according to histology: a population-based analysis of incidence and temporal trends","author":"Rustgi","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.beem.2023.101786_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/den.14529","article-title":"Clinical characteristics and long-term prognosis of type 1 gastric neuroendocrine tumors in a large Japanese national cohort","author":"Namikawa","year":"2023","journal-title":"Dig Endosc"},{"key":"10.1016\/j.beem.2023.101786_bib42","article-title":"Gastric neuroendocrine tumors according to the 2019 World Health organization grading system: a single-center, retrospective study","author":"Kim","year":"2023","journal-title":"Gut Liver"},{"key":"10.1016\/j.beem.2023.101786_bib43","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12020-021-02775-1","article-title":"Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms?","volume":"74","author":"Exarchou","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2023.101786_bib44","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1245\/s10434-018-6673-5","article-title":"Heterogeneity of duodenal neuroendocrine tumors: an italian multi-center experience","volume":"25","author":"Massironi","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.beem.2023.101786_bib45","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ejso.2020.01.030","article-title":"Surgical resection for duodenal neuroendocrine neoplasia: outcome, prognostic factors and risk of metastases","volume":"46","author":"Nie\u00dfen","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.beem.2023.101786_bib46","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1111\/jgh.15586","article-title":"Favorable long-term outcomes of endoscopic resection for nonampullary duodenal neuroendocrine tumor","volume":"36","author":"Matsueda","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.beem.2023.101786_bib47","first-page":"265","article-title":"Short- and long-term outcomes of endoscopic submucosal dissection for non-ampullary duodenal neuroendocrine tumors","volume":"33","author":"Nishio","year":"2020","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.beem.2023.101786_bib48","doi-asserted-by":"crossref","first-page":"15762","DOI":"10.1038\/s41598-022-19738-9","article-title":"Diagnostic features and management options for duodenal neuroendocrine neoplasms: a retrospective, multi-centre study","volume":"12","author":"Mandair","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.beem.2023.101786_bib49","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1159\/000508102","article-title":"Management and prognosis of localized duodenal neuroendocrine neoplasms","volume":"111","author":"Gay-Chevallier","year":"2021","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2023.101786_bib50","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1159\/000511613","article-title":"\"Watch and wait\" strategy involving regular endoscopic surveillance is safe for many patients with small, sporadic, grade 1, non-ampullary, non-functioning duodenal neuroendocrine tumours","volume":"111","author":"Exarchou","year":"2021","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2023.101786_bib51","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00423-016-1537-6","article-title":"Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature","volume":"402","author":"Iwasaki","year":"2017","journal-title":"Lange Arch Surg"},{"key":"10.1016\/j.beem.2023.101786_bib52","doi-asserted-by":"crossref","first-page":"459","DOI":"10.15403\/jgld-4383","article-title":"Somatostatinoma of the ampulla of vater: a systematic review","volume":"31","author":"Giannakodimos","year":"2022","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.beem.2023.101786_bib53","doi-asserted-by":"crossref","DOI":"10.1007\/s40618-022-01961-w","article-title":"Sporadic and MEN1-related gastrinoma and Zollinger-Ellison syndrome: differences in clinical characteristics and survival outcomes","author":"Massironi","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.beem.2023.101786_bib54","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/gutjnl-2020-322595","article-title":"Non-functional pancreatic neuroendocrine tumours: ATRX\/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX\/PDX1 expression and tumour size","volume":"71","author":"Hackeng","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.beem.2023.101786_bib55","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.path.2022.05.007","article-title":"Prognostic and predictive biomarkers for pancreatic neuroendocrine tumors","volume":"15","author":"Hackeng","year":"2022","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.beem.2023.101786_bib56","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000503833","article-title":"Prospective study of chromogranin A as a predictor of progression in patients with pancreatic, small-intestinal, and unknown primary neuroendocrine tumors","volume":"110","author":"Dam","year":"2020","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2023.101786_bib57","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.hpb.2018.08.011","article-title":"The effect of centralization on short term outcomes of pancreatoduodenectomy in a universal health care system","volume":"21","author":"Nymo","year":"2019","journal-title":"HPB"},{"key":"10.1016\/j.beem.2023.101786_bib58","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jgo.2019.10.012","article-title":"In-hospital 30-day mortality for older patients with pancreatic cancer undergoing pancreaticoduodenectomy","volume":"11","author":"Shaib","year":"2020","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.beem.2023.101786_bib59","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/SLA.0000000000004315","article-title":"Outcome quality beyond the mean - an analysis of 43,231 pancreatic surgical procedures related to hospital volume","volume":"276","author":"Hunger","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2023.101786_bib60","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.amjsurg.2022.07.007","article-title":"Predictors of post-operative pancreatic fistula formation in pancreatic neuroendocrine tumors: A national surgical quality improvement program analysis","volume":"224","author":"Hedges","year":"2022","journal-title":"Am J Surg"},{"key":"10.1016\/j.beem.2023.101786_bib61","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.hpb.2019.06.004","article-title":"Pre-, peri- and post-operative factors for the development of pancreatic fistula after pancreatic surgery","volume":"21","author":"S\u00f8reide","year":"2019","journal-title":"HPB"},{"key":"10.1016\/j.beem.2023.101786_bib62","doi-asserted-by":"crossref","first-page":"202","DOI":"10.6004\/jnccn.2019.0014","article-title":"Pancreatic adenocarcinoma, version 1.2019","volume":"17","author":"Tempero","year":"2019","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.beem.2023.101786_bib63","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1093\/bjs\/znaa141","article-title":"Sporadic non-functioning pancreatic neuroendocrine tumours: multicentre analysis","volume":"108","author":"Ricci","year":"2021","journal-title":"Br J Surg"},{"key":"10.1016\/j.beem.2023.101786_bib64","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/bjs.9819","article-title":"Meta-analysis of surgical outcome after enucleation versus standard resection for pancreatic neoplasms","volume":"102","author":"H\u00fcttner","year":"2015","journal-title":"Br J Surg"},{"key":"10.1016\/j.beem.2023.101786_bib65","first-page":"888","article-title":"Watchful waiting for small non-functional pancreatic neuroendocrine tumours: nationwide prospective cohort study (PANDORA)","author":"Heidsma","year":"2021"},{"key":"10.1016\/j.beem.2023.101786_bib66","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/bjs\/znac267","article-title":"Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2\u2005cm: interim analysis of prospective ASPEN trial","volume":"109","author":"Partelli","year":"2022","journal-title":"Br J Surg"},{"key":"10.1016\/j.beem.2023.101786_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/jso.27280","article-title":"Outcomes after primary tumor resection of metastatic pancreatic neuroendocrine tumors: an analysis of the National Cancer Database","author":"Kaslow","year":"2023","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.beem.2023.101786_bib68","doi-asserted-by":"crossref","first-page":"69","DOI":"10.21037\/hbsn-22-238","article-title":"Surgery for metastatic pancreatic neuroendocrine tumors: a narrative review","volume":"12","author":"Williams","year":"2023","journal-title":"Hepatobil Surg Nutr"},{"key":"10.1016\/j.beem.2023.101786_bib69","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00268-022-06736-1","article-title":"Overall survival in patients with stage IV Pan-NET eligible for liver transplantation","volume":"47","author":"Kjaer","year":"2023","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2023.101786_bib70","first-page":"5","article-title":"Long-term outcome after resection and thermal hepatic ablation of pancreatic neuroendocrine tumour liver metastases","author":"Kjaer","year":"2021","journal-title":"BJS Open"},{"key":"10.1016\/j.beem.2023.101786_bib71","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1002\/cncr.31079","article-title":"Neuroendocrine tumors and fibrosis: an unsolved mystery?","volume":"123","author":"Laskaratos","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.beem.2023.101786_bib72","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/bjs.10333","article-title":"Clinical signs of fibrosis in small intestinal neuroendocrine tumours","volume":"104","author":"Daskalakis","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.beem.2023.101786_bib73","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000493317","article-title":"Evaluation of clinical prognostic factors and further delineation of the effect of mesenteric fibrosis on survival in advanced midgut neuroendocrine tumours","volume":"107","author":"Laskaratos","year":"2018","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2023.101786_bib74","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/ans.17851","article-title":"Survival of patients with small bowel neuroendocrine neoplasms in Auckland, Aotearoa New Zealand","volume":"92","author":"McGuinness","year":"2022","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.beem.2023.101786_bib75","article-title":"The overriding role of surgery and tumor grade for long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: a population-based cohort study","volume":"5","author":"S\u00f8reide","year":"2022","journal-title":"Cancer Rep"},{"key":"10.1016\/j.beem.2023.101786_bib76","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00268-020-05727-4","article-title":"Role of primary tumor resection for metastatic small bowel neuroendocrine tumors","volume":"45","author":"Hallet","year":"2021","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2023.101786_bib77","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1200\/JOP.18.00135","article-title":"Management of small bowel neuroendocrine tumors","volume":"14","author":"Scott","year":"2018","journal-title":"J Oncol Pr"},{"key":"10.1016\/j.beem.2023.101786_bib78","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1245\/s10434-018-6433-6","article-title":"Outcomes of cytoreductive surgery for metastatic low-grade neuroendocrine tumors in the setting of extrahepatic metastases","volume":"25","author":"Chan","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.beem.2023.101786_bib79","doi-asserted-by":"crossref","DOI":"10.1503\/cmaj.160771","article-title":"Principles of diagnosis and management of neuroendocrine tumours","volume":"189","author":"Raphael","year":"2017","journal-title":"Cmaj"},{"key":"10.1016\/j.beem.2023.101786_bib80","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1677\/ERC-09-0042","article-title":"Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study","volume":"16","author":"Ahmed","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2023.101786_bib81","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1007\/s11605-018-04094-9","article-title":"Is resection of primary midgut neuroendocrine tumors in patients with unresectable metastatic liver disease justified? a systematic review and meta-analysis","volume":"23","author":"Tsilimigras","year":"2019","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.beem.2023.101786_bib82","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13008","article-title":"Postoperative morbidity and mortality after surgical resection of small bowel neuroendocrine neoplasms: A systematic review and meta-analysis","volume":"33","author":"Ka\u00e7maz","year":"2021","journal-title":"J Neuroendocr"},{"key":"10.1016\/j.beem.2023.101786_bib83","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/jamaoncol.2018.2428","article-title":"Follow-up recommendations for completely resected gastroenteropancreatic neuroendocrine tumors","volume":"4","author":"Singh","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.beem.2023.101786_bib84","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jamasurg.2018.3865","article-title":"Prognostic role of lymph node positivity and number of lymph nodes needed for accurately staging small-bowel neuroendocrine tumors","volume":"154","author":"Zaidi","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.beem.2023.101786_bib85","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00268-013-1918-8","article-title":"Resection of at-risk mesenteric lymph nodes is associated with improved survival in patients with small bowel neuroendocrine tumors","volume":"37","author":"Landry","year":"2013","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2023.101786_bib86","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1177\/1457496919874484","article-title":"Primary small intestinal neuroendocrine tumors are highly prevalent and often multiple before metastatic disease develops","volume":"110","author":"Eriksson","year":"2021","journal-title":"Scand J Surg"},{"key":"10.1016\/j.beem.2023.101786_bib87","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/j.1572-0241.2007.01185.x","article-title":"A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress","volume":"102","author":"Modlin","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.beem.2023.101786_bib88","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1159\/000441423","article-title":"Toward a preoperative classification of lymph node metastases in patients with small intestinal neuroendocrine tumors in the era of intestinal-sparing surgery","volume":"103","author":"Lardi\u00e8re-Deguelte","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2023.101786_bib89","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1097\/SLA.0000000000004647","article-title":"Upfront small bowel resection for small bowel neuroendocrine tumors with synchronous metastases: a propensity-score matched comparative population-based analysis","volume":"276","author":"Bennett","year":"2022","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2023.101786_bib90","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.ejso.2017.05.016","article-title":"Role of palliative resection of the primary tumour in advanced pancreatic and small intestinal neuroendocrine tumours: a systematic review and meta-analysis","volume":"43","author":"Almond","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.beem.2023.101786_bib91","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000464292","article-title":"ENETS consensus guidelines for standard of care in neuroendocrine tumours: surgery for small intestinal and pancreatic neuroendocrine tumours","volume":"105","author":"Partelli","year":"2017","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2023.101786_bib92","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000478742","article-title":"Surgical management of patients with neuroendocrine neoplasms of the appendix: appendectomy or more","volume":"106","author":"Pawa","year":"2018","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2023.101786_bib93","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ecl.2018.04.004","article-title":"The problem of appendiceal carcinoids","volume":"47","author":"Galanopoulos","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.beem.2023.101786_bib94","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000493894","article-title":"Unmet needs in appendiceal neuroendocrine neoplasms","volume":"108","author":"Toumpanakis","year":"2019","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2023.101786_bib95","first-page":"15","article-title":"Management of appendix neuroendocrine neoplasms: insights on the current guidelines","author":"Mohamed","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.beem.2023.101786_bib96","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/SLA.0000000000002736","article-title":"Current management and predictive factors of lymph node metastasis of appendix neuroendocrine tumors: a national study from the french group of endocrine tumors (GTE)","volume":"270","author":"Rault-Petit","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2023.101786_bib97","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(22)00750-1","article-title":"Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1\u20132\u2009cm in size: a retrospective, Europe-wide, pooled cohort study","volume":"24","author":"Nesti","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.beem.2023.101786_bib98","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000493767","article-title":"Colorectal neuroendocrine neoplasms: areas of unmet need","volume":"108","author":"Ramage","year":"2019","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2023.101786_bib99","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/SLA.0b013e3181fb8df6","article-title":"Carcinoid tumors of the rectum: a multi-institutional international collaboration","volume":"252","author":"Shields","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.beem.2023.101786_bib100","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.14309\/ajg.0000000000001914","article-title":"Modified cap-assisted endoscopic mucosal resection versus endoscopic submucosal dissection for the treatment of rectal neuroendocrine tumors \u226410 mm: a randomized noninferiority trial","volume":"117","author":"Gao","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.beem.2023.101786_bib101","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00384-020-03793-7","article-title":"Outcomes of non-metastatic poorly differentiated gastroenteropancreatic neuroendocrine neoplasms treated with surgery: a real-world population-based study","volume":"36","author":"Abdel-Rahman","year":"2021","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.beem.2023.101786_bib102","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12967","article-title":"Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms","volume":"33","author":"Pommergaard","year":"2021","journal-title":"J Neuroendocr"},{"key":"10.1016\/j.beem.2023.101786_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188637","article-title":"Gastroenteropancreatic neuroendocrine neoplasms G3: novel insights and unmet needs","volume":"1876","author":"Shi","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.beem.2023.101786_bib104","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/jso.26928","article-title":"Surgical outcomes of gastro-entero-pancreatic neuroendocrine tumors G3 versus neuroendocrine carcinoma","volume":"126","author":"Li","year":"2022","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.beem.2023.101786_bib105","first-page":"16","article-title":"Treatment landscape of advanced high-grade neuroendocrine neoplasms","volume":"21","author":"Alheraki","year":"2023","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.beem.2023.101786_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.pan.2023.01.009","article-title":"Diagnostic role and prognostic value of tumor markers in high-grade gastro-enteropancreatic neuroendocrine neoplasms","author":"Gao","year":"2023","journal-title":"Pancreatology"},{"key":"10.1016\/j.beem.2023.101786_bib107","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1136\/gutjnl-2020-321300","article-title":"Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?","volume":"70","author":"Rinke","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.beem.2023.101786_bib108","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1245\/s10434-022-12643-5","article-title":"Surgical management of G3 gastroenteropancreatic neuroendocrine neoplasms: a systematic review and meta-analysis","volume":"30","author":"Ziogas","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.beem.2023.101786_bib109","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s11864-022-00969-x","article-title":"Surgery in patients with gastro-entero-pancreatic neuroendocrine carcinomas, neuroendocrine tumors G3 and high grade mixed neuroendocrine-non-neuroendocrine neoplasms","volume":"23","author":"Holmager","year":"2022","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.beem.2023.101786_bib110","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1245\/s10434-019-08049-5","article-title":"Surgery with radical intent: is there an indication for G3 neuroendocrine neoplasms?","volume":"27","author":"Merola","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.beem.2023.101786_bib111","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11154-018-9469-9","article-title":"Curative and palliative surgery in patients with neuroendocrine tumors of the gastro-entero-pancreatic (GEP) tract","volume":"19","author":"Goretzki","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.beem.2023.101786_bib112","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.surg.2015.05.040","article-title":"Liver-directed surgery of neuroendocrine metastases: what is the optimal strategy?","volume":"159","author":"Maxwell","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.beem.2023.101786_bib113","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41416-022-02061-5","article-title":"Dual [(68)Ga]DOTATATE and [(18)F]FDG PET\/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score","volume":"128","author":"Chan","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.beem.2023.101786_bib114","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s002680010236","article-title":"Gastrointestinal carcinoid tumors: long-term prognosis for surgically treated patients","volume":"24","author":"S\u00f6reide","year":"2000","journal-title":"World J Surg"},{"key":"10.1016\/j.beem.2023.101786_bib115","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/ijc.31137","article-title":"Survival in neuroendocrine neoplasms; a report from a large Norwegian population-based study","volume":"142","author":"Boyar Cetinkaya","year":"2018","journal-title":"Int J Cancer"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X2300060X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X2300060X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:59:37Z","timestamp":1761497977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X2300060X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":115,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1521690X2300060X"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2023.101786","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal surgical approach for digestive neuroendocrine neoplasia primaries: Oncological benefits versus short and long-term complications","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2023.101786","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101786"}}